Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 1:20 AM
Ignite Modification Date:
2025-12-25 @ 1:20 AM
NCT ID:
NCT06043193
Eligibility Criteria:
Inclusion Criteria:
* Age \>18 years;
* Patient starting treatment with RIV validated in the RENATEN RCP;
* Patient having received written information about the study;
* Collection of the patient's non-objection
* Patients for whom treatment with RIV is administered within the framework of a clinical trial, may be included in the AURARIV-TNE study according to the written indications written in the 2 nd protocol of the sponsor of the clinical trial;
* Patients undergoing re-treatment with RIV can be included;
Exclusion Criteria:
* Persons deprived of their liberty by a judicial or administrative decision;
* Adults subject to a legal protection measure (guardianship, curatorship);
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT06043193
Study Brief:
Protocol Section:
NCT06043193